-
INO Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Inovio Pharmaceuticals (INO)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 21.69 mm | 21.69 mm | 21.69 mm | 21.69 mm | 21.69 mm | 21.69 mm |
Cash burn (monthly) | 4.23 mm | (no burn) | 9.12 mm | 9.95 mm | 9.15 mm | 9.22 mm |
Cash used (since last report) | 22.84 mm | n/a | 49.17 mm | 53.68 mm | 49.35 mm | 49.76 mm |
Cash remaining | -1.16 mm | n/a | -27.49 mm | -32.00 mm | -27.66 mm | -28.07 mm |
Runway (months of cash) | -0.3 | n/a | -3.0 | -3.2 | -3.0 | -3.0 |
13F holders | Current |
---|---|
Total holders | 104 |
Opened positions | 23 |
Closed positions | 19 |
Increased positions | 35 |
Reduced positions | 13 |
13F shares | Current |
---|---|
Total value | 24.26 bn |
Total shares | 13.34 mm |
Total puts | 40.96 k |
Total calls | 193.54 k |
Total put/call ratio | 0.2 |
Largest owners | Shares | Value |
---|---|---|
Deep Track Capital | 3.12 mm | $5.71 bn |
BlackRock | 1.91 mm | $3.49 bn |
Vanguard | 1.67 mm | $3.06 bn |
Stonepine Capital Management | 1.05 mm | $1.92 bn |
AIGH Capital Management | 654.12 k | $1.20 bn |
BAC Bank of America | 640.99 k | $1.17 bn |
Geode Capital Management | 628.51 k | $1.15 bn |
STT State Street | 504.31 k | $922.88 mm |
Highbridge Capital Management | 300.00 k | $549.00 mm |
GS The Goldman Sachs Group, Inc. | 290.44 k | $531.50 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
27 Feb 25 | Laurent Humeau | RSU Common Stock | Grant | Acquire A | No | No | 0 | 22,098 | 0.00 | 22,098 |
27 Feb 25 | Laurent Humeau | Common Stock Option Common Stock | Grant | Acquire A | No | No | 1.94 | 27,402 | 53.16 k | 27,402 |
27 Feb 25 | Michael John Sumner | RSU Common Stock | Grant | Acquire A | No | No | 0 | 34,650 | 0.00 | 34,650 |
27 Feb 25 | Michael John Sumner | Common Stock Option Common Stock | Grant | Acquire A | No | No | 1.94 | 42,900 | 83.23 k | 42,900 |
27 Feb 25 | Jacqueline Elizabeth Shea | RSU Common Stock | Grant | Acquire A | No | No | 0 | 85,201 | 0.00 | 85,201 |
27 Feb 25 | Jacqueline Elizabeth Shea | Common Stock Option Common Stock | Grant | Acquire A | No | No | 1.94 | 105,649 | 204.96 k | 105,649 |
27 Feb 25 | Peter Kies | RSU Common Stock | Grant | Acquire A | No | No | 0 | 31,900 | 0.00 | 31,900 |
27 Feb 25 | Peter Kies | Common Stock Option Common Stock | Grant | Acquire A | No | No | 1.94 | 39,050 | 75.76 k | 39,050 |
26 Feb 25 | Laurent Humeau | Common Stock | Payment of exercise | Dispose F | No | No | 1.98 | 2,059 | 4.08 k | 29,559 |
26 Feb 25 | Laurent Humeau | Common Stock | Option exercise | Acquire M | No | No | 0 | 5,010 | 0.00 | 31,618 |